Get started
Author

Beat Flühmann

Observed names: B Flühmann, Flühmann Beat, Flühmann, Beat
ORCID: 0000-0002-3077-298X
Observed ORCID: 0000-0002-3077-298X
OpenAlex ID: A5037316005
How to Regulate Nonbiological Complex Drugs (NBCD) and Their Follow-on Versions: Points to Consider
2013 · Huub Schellekens, Sven Stegemann, et al. · The AAPS Journal · 123
PDF
Nanomedicines: The magic bullets reaching their target?
2018 · Beat Flühmann, Ioanna Ntai, et al. · European Journal of Pharmaceutical Sciences · 116
PDF
Equivalence of complex drug products: advances in and challenges for current regulatory frameworks
2017 · Leonie Hussaarts, Stefan Mühlebach, et al. · Annals of the New York Academy of Sciences · 93
PDF
The similarity question for biologicals and non-biological complex drugs
2015 · Daan J.A. Crommelin, Vinod P. Shah, et al. · European Journal of Pharmaceutical Sciences · 72
PDF
Nanoparticle iron medicinal products – Requirements for approval of intended copies of non-biological complex drugs (NBCD) and the importance of clinical comparative studies
2012 · Gerrit Borchard, Beat Flühmann, et al. · Regulatory Toxicology and Pharmacology · 67
Factors influencing safety and efficacy of intravenous iron-carbohydrate nanomedicines: From production to clinical practice
2020 · Niusha Nikravesh, Gerrit Borchard, et al. · Nanomedicine Nanotechnology Biology and Medicine · 57
PDF
Tackling the challenges of nanomedicines: are we ready?
2021 · John B Hertig, Vinod P Shah, et al. · American Journal of Health-System Pharmacy · 51
PDF
How to select a nanosimilar
2017 · Alain Astier, Amy Barton Pai, et al. · Annals of the New York Academy of Sciences · 45
PDF
Criticality of Surface Characteristics of Intravenous Iron–Carbohydrate Nanoparticle Complexes: Implications for Pharmacokinetics and Pharmacodynamics
2022 · Felix Funk, Beat Flühmann, et al. · International Journal of Molecular Sciences · 42
PDF
Differences Between Intravenous Iron Products: Focus on Treatment of Iron Deficiency in Chronic Heart Failure Patients
2019 · Alejandro Martin-Malo, Gerrit Borchard, et al. · ESC Heart Failure · 41
A pragmatic regulatory approach for complex generics through the U.S. FDA 505(j) or 505(b)(2) approval pathways
2021 · Kevin Klein, Gerrit Borchard, et al. · Annals of the New York Academy of Sciences · 37
PDF
Reflections on FDA Draft Guidance for Products Containing Nanomaterials: Is the Abbreviated New Drug Application (ANDA) a Suitable Pathway for Nanomedicines?
2018 · Marden Emily, Ntai Ioanna, et al. · The AAPS Journal · 30
PDF
The Growing Field of Nanomedicine and Its Relevance to Pharmacy Curricula
2021 · Volkmar Weissig, Tamer Elbayoumi, et al. · American Journal of Pharmaceutical Education · 28
PDF
The authorization of non-biological complex drugs (NBCDs) follow-on versions: specific regulatory and interchangeability rules ahead?
2013 · Stefan Mühlebach, Arnold Vulto, et al. · Generics and Biosimilars Initiative Journal · 23
PDF
Iron-carbohydrate complexes treating iron anaemia: Understanding the nano-structure and interactions with proteins through orthogonal characterisation
2024 · Leonard Krupnik, Jonathan Avaro, et al. · Journal of Controlled Release · 21
PDF
Iron Carbohydrate Complexes: Characteristics and Regulatory Challenges
2015 · Stefan Mühlebach, Beat Flühmann · AAPS advances in the pharmaceutical sciences series · 18
Bonistein (synthetic genistein), a food component in development for a bone health nutraceutical.
2005 · U Ullmann, I Bendik, et al. · PubMed · 18
Kupffer Cells and Blood Monocytes Orchestrate the Clearance of Iron–Carbohydrate Nanoparticles from Serum
2022 · Tasneem Arsiwala, Anne-Cathrine S. Vogt, et al. · International Journal of Molecular Sciences · 15
PDF
Medication practice in hospitals: are nanosimilars evaluated and substituted correctly?
2017 · Josefien Knoeff, Beat Flühmann, et al. · European Journal of Hospital Pharmacy · 13
PDF
Putting square pegs in round holes: Why traditional pharmacokinetic principles cannot universally be applied to iron-carbohydrate complexes
2023 · Amy Barton Alston, Reinaldo Digigow, et al. · European Journal of Pharmaceutics and Biopharmaceutics · 12
Uncovering the dynamics of cellular responses induced by iron-carbohydrate complexes in human macrophages using quantitative proteomics and phosphoproteomics
2023 · Jonas Bossart, Alexandra Rippl, et al. · Biomedicine & Pharmacotherapy · 11
PDF
Need for Expansion of Pharmacy Education Globally for the Growing Field of Nanomedicine
2022 · Amy E. Barton, Gerrit Borchard, et al. · Pharmacy · 11
PDF
Correction to: Reflections on FDA Draft Guidance for Products Containing Nanomaterials: Is the Abbreviated New Drug Application (ANDA) a Suitable Pathway for Nanomedicines?
2018 · Emily Marden, Ioanna Ntai, et al. · The AAPS Journal · 11
PDF
Non-biological complex drugs (NBCDs) and their follow-on versions: time for an editorial section
2015 · Jon SB de Vlieger, Stefan Mühlebach, et al. · Generics and Biosimilars Initiative Journal · 10
PDF
Probing Subcellular Iron Availability with Genetically Encoded Nitric Oxide Biosensors
2022 · Gulsah Sevimli, Amy Alston, et al. · Biosensors · 9
PDF
Works count: 45
Citation count: 1,027
H-index: 17
I10-index: 24
Year
Topic
Type